캐뉼라 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 유형별, 재료별, 크기별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Cannula Market Growth & Trends:

The global cannula market size is expected to reach USD 294.6 million by 2030, registering to grow at a CAGR of 7.6% from 2024 to 2030 according to a new report by Grand View Research, Inc. Increase in the prevalence of lifestyle diseases and an increase in awareness about minimally invasive surgeries are primary factors driving the growth of the cannula market. Other factors such as a rise in government initiatives to raise awareness about chronic diseases, new product launches, and technological advancements are also expected to boost the growth of the market during the forecast period.

The market observed a mixed impact due to the pandemic. While the dermatology segment experienced a sudden fall in sales in the first half of the pandemic due to the postponement of elective surgeries to adhere to the government-led guidelines and restrictions to curb the spread of the virus. On the other hand, the nasal cannula experienced a rise in demand due to its usage to treat patients infected with the COVID-19 virus. The dermatology segment is expected to experience a considerable amount of growth during the forecast period with things returning to normal due to the rise in patients opting for cosmetic surgeries.

Cannula Market Report Highlights:

• Based on product, the market is segmented into cardiac, dermatology, nasal and others. The cardiac segment held the highest share in 2023 owing to the rise in the prevalence of cardiac diseases.
• Based on type, the market is classified into neonatal cannulae, straight cannulae, winged cannulae, a wing with port, and winged with stopcork. The straight cannulae accounted for the highest market share in 2023 due to the high adoption rate as it is simpler to use.
• Based on material, the is segmented into plastic, metal, and silicone. The Plastic segment dominated the market in 2023 with the highest share due to its increase in adoption rate in both in-patient and out-patient procedures.
• Based on the size, the 18G size held the highest market share in 2023 owing to ease of use for both adults and adolescents to carry out a number of procedures.
• Based on end-use, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment dominated the market due to an increase in hospitalization rate for a number of treatments.
• In terms of region, North America accounted for the highest market share in 2023 owing to the availability of advanced healthcare infrastructure, increase in adoption of plastic surgery, and favorable government initiatives.
• The COVID-19 pandemic had a mixed impact on the cannula market. While the dermatology segment experienced a significant fall in sales in the first half of the pandemic, the nasal cannula registered a major boost in sales during the pandemic.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Product
  • 1.2.2. Type
  • 1.2.3. Material
  • 1.2.4. Size
  • 1.2.5. End Use
• 1.3. Information analysis
• 1.4. Market formulation & data visualization
• 1.5. Data validation & publishing
• 1.6. Information Procurement
  • 1.6.1. Primary Research
• 1.7. Information or Data Analysis
• 1.8. Market Formulation & Validation
• 1.9. Market Model
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Insights Landscape

Chapter 3. Cannula Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook.
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increase in demand for minimally invasive surgeries
    • 3.2.1.2. Rise in the number of surgeries in geriatric population
    • 3.2.1.3. Increase in prevalence of lifestyle-related diseases
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Stringent regulations
    • 3.2.2.2. Lack of skilled professionals
• 3.3. Cannula Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTEL Analysis
  • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Cannula Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Cannula Market Product Movement Analysis
• 4.3. Global Cannula Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Cardiac
  • 4.4.1. Cardiac market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.2. Arterial
    • 4.4.2.1. Arterial market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.3. Venous
    • 4.4.3.1. Venous market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.4. Cardioplegia
    • 4.4.4.1. Cardioplegia market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.4.5. Femoral
    • 4.4.5.1. Femoral market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Dermatology
  • 4.5.1. Dermatology market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Nasal
  • 4.6.1. Nasal market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. Others
  • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cannula Market: Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Cannula Market Type Movement Analysis
• 5.3. Global Cannula Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
• 5.4. Neonatal Cannula
  • 5.4.1. Neonatal cannula market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Straight Cannula
  • 5.5.1. Straight cannula market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Winged Cannula
  • 5.6.1. Winged cannula market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Wing with port
  • 5.7.1. Wing with port market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Winged with stop cork
  • 5.8.1. Winged with stop cork market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cannula Market: Material Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Cannula Market Material Movement Analysis
• 6.3. Global Cannula Market Size & Trend Analysis, by Material, 2018 to 2030 (USD Million)
• 6.4. Plastic
  • 6.4.1. Plastic market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Metal
  • 6.5.1. Metal market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Silicone
  • 6.6.1. Silicone market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cannula Market: Size Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Cannula Market Size Movement Analysis
• 7.3. Global Cannula Market Size & Trend Analysis, by Size, 2018 to 2030 (USD Million)
• 7.4. 14G
  • 7.4.1. 14G market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. 16G
  • 7.5.1. 16G market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. 18G
  • 7.6.1. 18G market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. 20G
  • 7.7.1. 20G market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. 22G
  • 7.8.1. 22G market estimates and forecasts 2018 to 2030 (USD Million)
• 7.9. 24G
  • 7.9.1. 24G market estimates and forecasts 2018 to 2030 (USD Million)
• 7.10. 26G
  • 7.10.1. 26G Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cannula Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Cannula Market End Use Movement Analysis
• 8.3. Global Cannula Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 8.4. Hospital
  • 8.4.1. Hospital market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Ambulatory Surgical Centers
  • 8.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Others
  • 8.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Cannula Market: Regional Estimates & Trend Analysis by Product, Type, Material, Size, , and End Use

• 9.1. Regional Market Share Analysis, 2023 & 2030
• 9.2. Regional Market Dashboard
• 9.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 9.4. North America
  • 9.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.2. U.S.
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Regulatory framework
    • 9.4.2.3. Competitive scenario
    • 9.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.3. Canada
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Regulatory framework
    • 9.4.3.3. Competitive scenario
    • 9.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.4.4. Mexico
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Regulatory framework
    • 9.4.4.3. Competitive scenario
    • 9.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Europe
  • 9.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.2. UK
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Regulatory framework
    • 9.5.2.3. Competitive scenario
    • 9.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.3. Germany
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Regulatory framework
    • 9.5.3.3. Competitive scenario
    • 9.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.4. France
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Regulatory framework
    • 9.5.4.3. Competitive scenario
    • 9.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.5. Italy
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Regulatory framework
    • 9.5.5.3. Competitive scenario
    • 9.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.6. Spain
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Regulatory framework
    • 9.5.6.3. Competitive scenario
    • 9.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.7. Norway
    • 9.5.7.1. Key country dynamics
    • 9.5.7.2. Regulatory framework
    • 9.5.7.3. Competitive scenario
    • 9.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.8. Sweden
    • 9.5.8.1. Key country dynamics
    • 9.5.8.2. Regulatory framework
    • 9.5.8.3. Competitive scenario
    • 9.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.5.9. Denmark
    • 9.5.9.1. Key country dynamics
    • 9.5.9.2. Regulatory framework
    • 9.5.9.3. Competitive scenario
    • 9.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Asia Pacific
  • 9.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.2. Japan
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Regulatory framework
    • 9.6.2.3. Competitive scenario
    • 9.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.3. China
    • 9.6.3.1. Key country dynamics
    • 9.6.3.2. Regulatory framework
    • 9.6.3.3. Competitive scenario
    • 9.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.4. India
    • 9.6.4.1. Key country dynamics
    • 9.6.4.2. Regulatory framework
    • 9.6.4.3. Competitive scenario
    • 9.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.5. Australia
    • 9.6.5.1. Key country dynamics
    • 9.6.5.2. Regulatory framework
    • 9.6.5.3. Competitive scenario
    • 9.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.6. South Korea
    • 9.6.6.1. Key country dynamics
    • 9.6.6.2. Regulatory framework
    • 9.6.6.3. Competitive scenario
    • 9.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.6.7. Thailand
    • 9.6.7.1. Key country dynamics
    • 9.6.7.2. Regulatory framework
    • 9.6.7.3. Competitive scenario
    • 9.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 9.7. Latin America
  • 9.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.2. Brazil
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Regulatory framework
    • 9.7.2.3. Competitive scenario
    • 9.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.7.3. Argentina
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Regulatory framework
    • 9.7.3.3. Competitive scenario
    • 9.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 9.8. MEA
  • 9.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.2. South Africa
    • 9.8.2.1. Key country dynamics
    • 9.8.2.2. Regulatory framework
    • 9.8.2.3. Competitive scenario
    • 9.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.3. Saudi Arabia
    • 9.8.3.1. Key country dynamics
    • 9.8.3.2. Regulatory framework
    • 9.8.3.3. Competitive scenario
    • 9.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.4. UAE
    • 9.8.4.1. Key country dynamics
    • 9.8.4.2. Regulatory framework
    • 9.8.4.3. Competitive scenario
    • 9.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 9.8.5. Kuwait
    • 9.8.5.1. Key country dynamics
    • 9.8.5.2. Regulatory framework
    • 9.8.5.3. Competitive scenario
    • 9.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Company/Competition Categorization
• 10.2. Strategy Mapping
• 10.3. Company Market Position Analysis, 2023
• 10.4. Company Profiles/Listing
  • 10.4.1. Medtronic
    • 10.4.1.1. Company overview
    • 10.4.1.2. Financial performance
    • 10.4.1.3. Product benchmarking
    • 10.4.1.4. Strategic initiatives
  • 10.4.2. Becton Dickinson (BD)
    • 10.4.2.1. Company overview
    • 10.4.2.2. Financial performance
    • 10.4.2.3. Product benchmarking
    • 10.4.2.4. Strategic initiatives
  • 10.4.3. Edward Lifesciences
    • 10.4.3.1. Company overview
    • 10.4.3.2. Financial performance
    • 10.4.3.3. Product benchmarking
    • 10.4.3.4. Strategic initiatives
  • 10.4.4. LivaNova
    • 10.4.4.1. Company overview
    • 10.4.4.2. Financial performance
    • 10.4.4.3. Product benchmarking
    • 10.4.4.4. Strategic initiatives
  • 10.4.5. Smiths Medical
    • 10.4.5.1. Company overview
    • 10.4.5.2. Financial performance
    • 10.4.5.3. Product benchmarking
    • 10.4.5.4. Strategic initiatives
  • 10.4.6. Boston Scientific Corporation
    • 10.4.6.1. Company overview
    • 10.4.6.2. Financial performance
    • 10.4.6.3. Product benchmarking
    • 10.4.6.4. Strategic initiatives